rivaroxaban
Showing 26 - 50 of 674
Left Ventricular Thrombus, Myocardial Infarction Trial (Rivaroxaban, Warfarin)
Not yet recruiting
- Left Ventricular Thrombus
- Myocardial Infarction
- Rivaroxaban
- Warfarin
- (no location specified)
Mar 31, 2023
Dose Optimization of Rivaroxaban Combined With Rifampicin
Recruiting
- Infections
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Dec 17, 2022
Anticoagulant Therapy Trial in Mannheim (Apixaban 5 MG Tab, Dabigatran 150 MG Tab, Edoxaban 60Mg Tab)
Active, not recruiting
- Anticoagulant Therapy
- Apixaban 5 MG Tab
- +3 more
-
Mannheim, GermanyClincial Research Serivces
Aug 4, 2022
Radial Artery Occlusion Trial in Rochester (Rivaroxaban)
Not yet recruiting
- Radial Artery Occlusion
- Rivaroxaban
-
Rochester, MinnesotaMayo Clinic Rochester
Aug 16, 2022
Excessive Supraventricular Ectopies or Short Atrial Runs (ESVEA) Trial (Rivaroxaban group)
Not yet recruiting
- Excessive Supraventricular Ectopies or Short Atrial Runs (ESVEA)
- Rivaroxaban group
- (no location specified)
Aug 2, 2022
Rivaroxaban - Percutaneous Coronary Intervention
Completed
- Coronary Artery Disease
- Atrial Fibrillation
- In vitro heparin
-
Bursa, TurkeyBursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi
Sep 13, 2022
Gather Information About Rivaroxaban in United Kingdom Who Have
Completed
- Treatment of Venous Thromboembolism in Cancer Patients
- Rivaroxaban (Xarelto, BAY59-7939)
- +2 more
-
Multiple Locations, United KingdomMany locations
Sep 19, 2022
Type II Myocardial Infarction Trial in Edmonton (Rivaroxaban 2.5 MG [Xarelto], Placebo)
Recruiting
- Type II Myocardial Infarction
- Rivaroxaban 2.5 MG [Xarelto]
- Placebo
-
Edmonton, Alberta, CanadaUniversity of Alberta
May 19, 2022
Chronic Hemodialysis Patients Trial (Rivaroxaban)
Not yet recruiting
- Chronic Hemodialysis Patients
- Rivaroxaban
- (no location specified)
Jun 2, 2022
Multiple Myeloma in Relapse, Multiple Myeloma Progression, Multiple Myeloma Stage II Trial in London (Rivaroxaban, ASA)
Recruiting
- Multiple Myeloma in Relapse
- +5 more
- Rivaroxaban
- ASA
-
London, Ontario, CanadaLondon Health Sciences Centre
Oct 3, 2022
Acute Coronary Syndrome Trial (Rivaroxaban 2.5 Mg Oral Tablet, Clopidogrel tablet, Aspirin tablet)
Not yet recruiting
- Acute Coronary Syndrome
- Rivaroxaban 2.5 Mg Oral Tablet
- +2 more
- (no location specified)
Oct 5, 2022
Ventricular Mural Thrombosis Trial in Beijing (Rivaroxaban)
Recruiting
- Ventricular Mural Thrombosis
- Rivaroxaban
-
Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences & Pecking Un
Jun 24, 2022
Gather Information About Rivaroxaban in Sweden With Cancer Who
Active, not recruiting
- Treatment of Venous Thromboembolism in Cancer Patients
- Rivaroxaban (Xarelto, BAY59-7939)
- +3 more
-
Multiple Locations, Many Locations, SwedenSwedish registries
Aug 18, 2022
Nonvalvular Atrial Fibrillation Trial in Angers (Rivaroxaban 20 MG, Warfarin)
Recruiting
- Nonvalvular Atrial Fibrillation
- Rivaroxaban 20 MG
- Warfarin
-
Angers, FranceAngers University Hospital
Jul 25, 2022
Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban
Active, not recruiting
- Treatment of Venous Thromboembolism in Cancer Patients
- +2 more
- Rivaroxaban (Xarelto, BAY59-7939)
- Apixaban
-
Wuppertal, GermanyBayer
Jul 25, 2022
Healthy Trial in Saint-etienne (Rivaroxaban, Activated charcoal)
Recruiting
- Healthy
- Rivaroxaban
- Activated charcoal
-
Saint-etienne, FranceCHU de SAINT-ETIENNE
Feb 14, 2022
Hip Fractures Trial in Calgary (Rivaroxaban 10mg, acetylsalicylic acid (ASA) 81mg Oral Tablet)
Not yet recruiting
- Hip Fractures
- Rivaroxaban 10mg
- acetylsalicylic acid (ASA) 81mg Oral Tablet
-
Calgary, Alberta, CanadaFoothills Medical Centre
Mar 7, 2023
Kidney's Ability to Work Properly in Korean Non-valvular Atrial
Active, not recruiting
- Non-valvular Atrial Fibrillation (NVAF)
- Rivaroxaban (Xarelto, BAY59-7939)
- Warfarin
-
Multiple Locations, Korea, Republic ofMany locations
Aug 11, 2022
Effectiveness of Rivaroxaban When Given Together With
Recruiting
- Prevention of Atherothrombotic Events
- +2 more
- Rivaroxaban (Xarelto,Bay 59-7939)
- Acetylsalicylic acid(ASA)
-
Multiple Locations, IndiaMany locations
Aug 22, 2022
Coronary Artery Disease (CAD), Peripheral Arterial Disease (PAD) Trial in Netherlands (Rivaroxaban 2.5 MG [Xarelto])
Active, not recruiting
- Coronary Artery Disease (CAD)
- Peripheral Arterial Disease (PAD)
- Rivaroxaban 2.5 MG [Xarelto]
-
Amsterdam, Netherlands
- +11 more
Sep 27, 2022
Valvular Heart Disease Trial in São Paulo (Rivaroxaban, Warfarin)
Completed
- Valvular Heart Disease
- Rivaroxaban
- Warfarin
-
São Paulo, SP, BrazilAssociação do Sanatório Sírio - Hospital do Coração HCor
Apr 4, 2022
Cancer Associated Thrombosis for Rivaroxaban - United States
Completed
- Treatment of Venous Thromboembolism in Cancer Patients
- Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients
- Rivaroxaban (Xarelto, BAY59-7939)
- +2 more
-
Multiple Locations, ConnecticutMany Locations
May 18, 2022
Rivaroxaban Versus Low-molecular-weight Heparin and
Completed
- Venous Thromboembolism
- Rivaroxaban (Xarelto, BAY 59-7939)
- LMWH and Phenprocoumon
-
Multiple Locations, GermanyMultiple facilities
Apr 27, 2022
Cerebral Infarction, TIA Trial in Shenyang (Rivaroxaban)
Recruiting
- Cerebral Infarction
- TIA
- Rivaroxaban
-
Shenyang, ChinaGeneral Hospital of ShenYang Military Region
Feb 20, 2022
Deep Venous Thrombosis, Colonic Cancer Trial in São Paulo (Rivaroxaban 10 MG)
Not yet recruiting
- Deep Venous Thrombosis
- Colonic Cancer
- Rivaroxaban 10 MG
-
São Paulo, SP, BrazilHospital do Servidor Público Estadual de São Paulo
Mar 21, 2022